VALLEY COTTAGE, New York, February 2, 2018 /PRNewswire/ --
Future Market Insights presents a new report titled 'HepatitisB Diagnostic Tests Market: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027' that studies the performance of the global hepatitis B diagnostic tests market over a 10 year assessment period from 2017 to 2027. The report presents
(Logo: http://photos.prnewswire.com/prnh/20161020/430874LOGO )
High Prevalence of Hepatitis B in the APEJ Region Boosting Global Market Revenue Growth
The prevalence of hepatitis B is highest in the APEJ region and the disease burden caused by chronic cases of hepatitis B is enormous. APEJ region has more number of chronic hepatitis B patients than any other region in the world and is thus a potential market for hepatitis B test kit manufacturers. As per the data provided by WHO, China accounts for one-third of all chronic hepatitis B infections. In addition, 6.2% of the adult population in the Western Pacific region is infected with hepatitis B. In the South-East Asia region, an estimated 2% of the general population is infected with hepatitis B. According to Hepatitis Australia, approximately 225,000 people are living with chronic hepatitis B in the country. As per the data provided by WHO, in India, the prevalence of hepatitis B surface antigen is 3%-4.2% with over 40 million hepatitis B carriers. Due to such high prevalence of hepatitis B in the APEJ region, the market for hepatitis B diagnostic tests has a huge potential in the region.
Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-1332
Global Hepatitis B Diagnostic Tests Market: Segmentation and Forecast
The global hepatitis B diagnostic tests market is segmented on the basis of product type, end user and region.
Preview Analysis on Global Hepatitis B Diagnostic Tests Market Segmentation: By Product Type: Enzyme Immunoassay Kits - Hepatitis B Surface Antigen Test, Anti-Hepatitis B Surface Antibody Test, Anti-Hepatitis B Core Antibody Test; Point-of-Care Testing Kits: Strips, Cassettes/Cards; By End User: Hospitals, Clinics, Diagnostic Centres, Home Care: https://www.futuremarketinsights.com/reports/hepatitis-b-diagnostic-test-market
Global Hepatitis B Diagnostic Tests Market: Competitive Landscape
This report features some of the important players functioning in the global hepatitis B diagnostic tests market such as bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Abbott Laboratories, Meridian Bioscience, Inc., Vista Diagnostics International, Biogate Laboratories Ltd., J.Mitra & Co. Ltd., Siemens Medical Solutions USA, Inc. and General Biologicals Corporation.
Our advisory services are aimed at helping you with specific, customised insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-1332
More from FMI's Cutting-edge Intelligence:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.
Browse More Healthcare, Pharmaceuticals and Medical devices Market Insights
Contact Us 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): +44(0)20-7692-8790 Sales: firstname.lastname@example.org Press Office: Press@futuremrketinsights.com
FMI Blog: http://www.fmiblog.com/
SOURCE Future Market Insights
Subscribe to our Free Newsletters!